Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
253 6 |
Ultima descărcare din IBN: 2024-03-16 20:13 |
Căutarea după subiecte similare conform CZU |
616.36-002-07:616.24-002.5 (1) |
Заболевания пищеварительной системы. Болезнь пищеварительного тракта (1698) |
Заболевания дыхательной системы (747) |
SM ISO690:2012 SAJIN, Octavian, SPÎNU, Constantin, ISAC, Maria, IZIUMOV, Nina, CHERNIAVSKA (MIRON), Aliona, BUGA, Alexandru, CIOBANU, Igor. Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova. In: One Health and Risk Management, 2023, nr. 4(1), pp. 59-64. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2023.1.07 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
One Health and Risk Management | |||||
Numărul 4(1) / 2023 / ISSN 2587-3458 /ISSNe 2587-3466 | |||||
|
|||||
DOI: https://doi.org/10.38045/ohrm.2023.1.07 | |||||
CZU: 616.36-002-07:616.24-002.5 | |||||
Pag. 59-64 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Introduction. For the first time, in the Republic of Moldova, there was established the seroprevalence of viral hepatitis B, C and E markers in patients with tuberculosis depending on gender, age and geographical areas. Material and methods. 200 blood samples were collected from patients with tuberculosis and tested by the immuno-fermentative method for presence of viral hepatitis B, C and E markers. Results. Following the investigations, it was established that the seroprevalence of the anti HEV Ig marker in patients with tuberculosis is 12.0±2.3%. The seroprevalence of viral hepatitis B marker HBsAg in patients with tuberculosis was 13.5±2.4%, and that of viral hepatitis C anti HCV – 9.0±2.0%. The study of investigations results for the presence of nominated markers depending on the geographical areas showed a significant statistically difference in the seroprevalence of the anti-HEV IgG marker in TB patients in the Central area of the country compared to the Southern area(p<0.05). Conclusions. Patients with tuberculosis showed a high level of seroprevalence of viral hepatitis marker viz. HBsAg - 13.5±2.4%; anti-HVC - 9.0±2.0% and anti-HVE IgG - 12.0±2.3%. People aged 40-49 and > 60 years were the most affected, including males. |
|||||
Cuvinte-cheie seroprevalence, laboratory investigations, viral hepatitis B, C and E, TB patients, seroprevalenţa, investigații de laborator, hepatitele virale B, C și E, bolnavii cu tuberculoză |
|||||
|